asia healthspace

Today, I stumbled upon a new, very interesting blog concept started by Adam Marcus and Ivan Oransky, addressing scientific journalism and its accuracy: Retraction Watch. In the pursuit of accountability you have to love the web enabling blogs and organizations like this, Wikileaks, and other independent forms of investigative journalism and expression. Old school media [...]

A recent reader, Nonoy Oplas, who heads a think tank in the Philippines called Minimal Government alerted our attention today (see comments under DR. ARROYO AND THE ‘LAW OF INTENDED CONSEQUENCES’ and DEAR DR. ARROYO, JUST WHAT MEDICINE ARE YOU PRESCRIBING?) to yet another apparently unintended consequence of political interference in the Philippines healthcare industry [...]

Medical tourism – the practice of traveling to another country for healthcare reasons and enjoying a holiday at the same time is a key economic growth drivers that countries with advanced medical infrastructure and capabilities are looking at developing. Most countries offering medical tourism lure potential customers by offering cost-effective yet quality delivery of complex [...]

As a follow-up to Dr. Arroyo and the ‘Law of INTENDED Consequences’ And from our friends at BioSpectrum Asia Pfizer takes Dr Reddy’s to court over Lipitor Bangalore, Dec 14, 2009: American Drug maker Pfizer has asked a judge to bar the sale of a generic version of Lipitor, developed by Dr Reddy’s Laboratories, one [...]

Clearstate analysis of interventional cardiology products’ market opportunity in China reveals a huge market set to experience exceptional growth across several product segments over the next few years. The market is expanding in line with a dramatic rise in cardiovascular disease among increasingly affluent and urbanised Chinese, with the resulting surge in demand for high [...]

A recent Clearstate study found nascent but growing demand for platelet aphaeresis in India, driven by disease outbreaks, procedural demand and clinician awareness. Blood banking infrastructure: India maintains a heterogeneous system of blood banks run by government, private hospitals and independent organisations. There are about 2600 blood banks in India. Roughly one-third of all blood [...]

Fabulous tool from the folks at GE…bringing good things to life The below image is a snapshot of a new interactive “wheel” tool released by GE to help understand and analyze the cost of delivering healthcare. Please visit the link above to “play” with it. This tool is an interactive wheel where one can select [...]

Here is the refresher (DEAR DR. ARROYO, JUST WHAT MEDICINE ARE YOU PRESCRIBING?)…. And now the consequences… An article Pfizer takes aim in patent row, posted today in our Financial Times. I quote my previous view from the above mentioned blog post: If I recall, if we fix the price “p” at below what is [...]

Memo: To All American Surgeons Dear Surgeons, Please understand that we sympathize with your demanding workloads especially under the scrutiny of litigious leaning patients and ‘high threshold-you have to need it’ utilization review committees at HMO’s, however, we feel strongly that economies of scale will help drive down health care costs and we believe driving [...]

Thanks to the WSJ for catapulting me back into the blogosphere….. The Henry Ford of Heart Surgery In India, a Factory Model for Hospitals Is Cutting Costs and Yielding Profits This analogy definitely requires a comment or two. The above linked article was presented by Geeta Anand in the Wall Street Journal a couple a [...]

Our chairman who art at Goldman, Blankfein be thy name, Thy rally’s come, God’s work be done, In the Dow as it is in the Nasdaq, Give us this day our daily gain, And forgive us our frontruning, as we punish those who frontrun against us, And bring us not under indictment, But deliver us [...]